Send me a link:

*Text messaging rates may apply.

 Dow Up 0.36% Nasdaq Up 0.71%

NeurogesX, Inc. (NGSX)

-Other OTC
0.00 0.00(47.50%) Jul 22, 3:23PM EDT
Prev Close:0.01
Open:0.01
Bid:N/A
Ask:N/A
1y Target Est:1.00
Beta:1.52
Next Earnings Date:N/A
Day's Range:0.00 - 0.01
52wk Range:0.00 - 0.41
Volume:118,200
Avg Vol (3m):81,109
Market Cap:140.34K
P/E (ttm):N/A
EPS (ttm):-0.96
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NGSXDown 47.50%140.34K
LLY68.35B
ENDP10.59B
PFE194.49B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):0.02
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (0-00-31) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NeurogesX, Inc., a biopharmaceutical company, engages in developing and commercializing pain management therapies. The company offers Qutenza for the management of neuropathic pain associated with postherpetic neuralgia, and for the treatment of p... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback